Literature DB >> 25158186

Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth.

B Salmon1, C Bardet, B R Coyac, B Baroukh, J Naji, P S Rowe, S Opsahl Vital, A Linglart, M D Mckee, C Chaussain.   

Abstract

Mutations in phosphate-regulating gene (PHEX) lead to X-linked hypophosphatemic rickets (XLH), a genetic disease characterized by impaired mineralization in bones and teeth. In human XLH tooth dentin, calcospherites that would normally merge as part of the mineralization process are separated by unmineralized interglobular spaces where fragments of matrix proteins accumulate. Here, we immunolocalized osteopontin (OPN) in human XLH teeth, in a three-dimensional XLH human dental pulp stem cell-collagen scaffold culture model and in a rat tooth injury repair model treated with acidic serine- and aspartate-rich motif peptides (ASARM). In parallel, matrix extracellular phosphoglycoprotein (MEPE) immunolocalization and alkaline phosphatase (ALP) activity were assessed in XLH teeth. OPN was expressed by odontoblasts in the XLH models, and localized to the abnormal calcospherites of XLH tooth dentin. In addition, ALP activity and MEPE localization were abnormal in human XLH teeth, with MEPE showing an accumulation in the unmineralized interglobular spaces in dentin. Furthermore, XLH odontoblasts failed to form a well-polarized odontoblast layer. These data suggest that both MEPE and OPN are involved in impaired tooth mineralization associated with XLH, possibly through different effects on the mineralization process.

Entities:  

Keywords:  Alkaline phosphatase; X-linked hypophosphatemia (XLH); acidic serine- and aspartate-rich motif (ASARM); dentin; matrix extracellular phosphoglycoprotein (MEPE); odontoblast; osteopontin

Mesh:

Substances:

Year:  2014        PMID: 25158186     DOI: 10.3109/03008207.2014.923864

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  12 in total

1.  Osteopontin regulates dentin and alveolar bone development and mineralization.

Authors:  B L Foster; M Ao; C R Salmon; M B Chavez; T N Kolli; A B Tran; E Y Chu; K R Kantovitz; M Yadav; S Narisawa; J L Millán; F H Nociti; M J Somerman
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

2.  Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Authors:  Erik A Imel; Francis H Glorieux; Michael P Whyte; Craig F Munns; Leanne M Ward; Ola Nilsson; Jill H Simmons; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Pisit Pitukcheewanont; Etienne Sochett; Wolfgang Högler; Koji Muroya; Hiroyuki Tanaka; Gary S Gottesman; Andrew Biggin; Farzana Perwad; Meng Mao; Chao-Yin Chen; Alison Skrinar; Javier San Martin; Anthony A Portale
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

3.  Compositional and microhardness findings in tooth affected by X-linked hypophosphatemic rickets.

Authors:  Francisco-Samuel-Rodrigues Carvalho; Victor-Pinheiro Feitosa; Cristiane-Sá Roriz Fonteles; Thyciana-Rodrigues Ribeiro; Bruno-Sousa Araújo; Alejandro-Pedro Ayala; Fábio-Wildson-Gurgel Costa
Journal:  J Clin Exp Dent       Date:  2020-07-01

4.  Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.

Authors:  Leanne M Ward; Francis H Glorieux; Michael P Whyte; Craig F Munns; Anthony A Portale; Wolfgang Högler; Jill H Simmons; Gary S Gottesman; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Ola Nilsson; Meng Mao; Angel Chen; Alison Skrinar; Mary Scott Roberts; Erik A Imel
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

Review 5.  Between a rock and a hard place: Regulation of mineralization in the periodontium.

Authors:  Natalie L Andras; Fatma F Mohamed; Emily Y Chu; Brian L Foster
Journal:  Genesis       Date:  2022-04-23       Impact factor: 2.389

6.  Insights into dental mineralization from three heritable mineralization disorders.

Authors:  Michael B Chavez; Kaitrin Kramer; Emily Y Chu; Vivek Thumbigere-Math; Brian L Foster
Journal:  J Struct Biol       Date:  2020-08-03       Impact factor: 2.867

7.  Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif.

Authors:  Lesya V Zelenchuk; Anne-Marie Hedge; Peter S N Rowe
Journal:  Bone       Date:  2015-06-04       Impact factor: 4.398

8.  Pulp chamber features, prevalence of abscesses, disease severity, and PHEX mutation in X-linked hypophosphatemic rickets.

Authors:  Giampiero I Baroncelli; Elisa Zampollo; Mario Manca; Benedetta Toschi; Silvano Bertelloni; Angela Michelucci; Alessandro Isola; Alessandra Bulleri; Diego Peroni; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2020-08-08       Impact factor: 2.626

9.  Effects of Active Vitamin D or FGF23 Antibody on Hyp Mice Dentoalveolar Tissues.

Authors:  E J Lira Dos Santos; M B Chavez; M H Tan; F F Mohamed; T N Kolli; B L Foster; E S Liu
Journal:  J Dent Res       Date:  2021-04-27       Impact factor: 6.116

10.  Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals.

Authors:  Danila de Oliveira; Jaqueline Suemi Hassumi; Pedro Henrique da Silva Gomes-Ferreira; Tárik Ocon Braga Polo; Gabriel Ramalho Ferreira; Leonardo Perez Faverani; Roberta Okamoto
Journal:  J Appl Oral Sci       Date:  2017 Jan-Feb       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.